ondansetron and dinaciclib

ondansetron has been researched along with dinaciclib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bannerji, R; Kantesaria, B; Mita, M; Poon, J; Shapiro, GI; Small, K; Statkevich, P; Tzontcheva, A; Zhang, D; Zhu, Y	1

Trials

1 trial(s) available for ondansetron and dinaciclib

Article	Year
Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:6 Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Agents; Aprepitant; Area Under Curve; Bridged Bicyclo Compounds, Heterocyclic; Cross-Over Studies; Cyclic N-Oxides; Cyclin-Dependent Kinases; Dexamethasone; Drug Administration Schedule; Female; Half-Life; Humans; Indolizines; Infusions, Intravenous; Linear Models; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Ondansetron; Pyridinium Compounds; Treatment Failure; Vomiting	2012

Article

Year

Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies.

Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:6

Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Antiemetics; Antineoplastic Agents; Aprepitant; Area Under Curve; Bridged Bicyclo Compounds, Heterocyclic; Cross-Over Studies; Cyclic N-Oxides; Cyclin-Dependent Kinases; Dexamethasone; Drug Administration Schedule; Female; Half-Life; Humans; Indolizines; Infusions, Intravenous; Linear Models; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Ondansetron; Pyridinium Compounds; Treatment Failure; Vomiting

2012